Tweet
Financial Express
<img alt="" height="1" width="1" />
Biocon's New Breast Cancer Drug CANMAb to Hit Markets Next Month
The New Indian Express
Biocon has announced a new drug for the treatment of HER2 positive metastatic breast cancer in the country. A biosimilar trastuzumab, CANMAb, developed jointly by Biocon and Mylan, will be the world's first biosimilar version of Herceptin and will be ...
Biocon's cancer drug not affordable: ActivistsDeccan Herald
Biocon releases drug to treat breast cancerBusiness Standard
In India, breast cancer treatment to become more affordableAl Jazeera America
Moneycontrol.com
all 54 news articles »
More...